Eagle Pharmaceuticals, Inc. (EGRX)
Market Closed
12 Jun, 20:00
OTC PINK OTC PINK Primary $
0. 61
0
0%
$
8.03M Market Cap
- P/E Ratio
- Div Yield
435 Volume
- Eps
$ 0.61
Previous Close Want to track EGRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
INVESTOR ALERT: Rigrodsky Law, P.A. Is Investigating Eagle Pharmaceuticals, Inc. On Behalf of Shareholders
WILMINGTON, DE / ACCESSWIRE / October 22, 2024 / Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company") (NASDAQ GM:EGRX) on behalf of stockholders.
Accesswire | 1 year ago
Union Square Park Capital Management's Strategic Acquisition of Eagle Pharmaceuticals Shares
On October 3, 2024, Union Square Park Capital Management, LLC (Trades, Portfolio) made a significant move in the pharmaceutical sector by acquiring 1,191,490 shares of Eagle Pharmaceuticals Inc (EGRX, Financial). This transaction marked a new holding for the firm, purchased at a price of $1.99 per share.
Gurufocus | 1 year ago
